Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer

<p>Abstract</p> <p>Background</p> <p>Breast cancers are phenotypically and genotypically heterogeneous tumors containing multiple cancer cell populations with various metastatic potential. Aggressive tumor cell subpopulations might more easily be captured in lymph nodes...

Full description

Bibliographic Details
Main Authors: Markiewicz Aleksandra, Ahrends Tomasz, Wełnicka-Jaśkiewicz Marzena, Seroczyńska Barbara, Skokowski Jarosław, Jaśkiewicz Janusz, Szade Jolanta, Biernat Wojciech, Żaczek Anna J
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://www.translational-medicine.com/content/10/1/226
id doaj-7a505cb52b8943c7b52fecf6cc00b0c0
record_format Article
spelling doaj-7a505cb52b8943c7b52fecf6cc00b0c02020-11-24T20:53:21ZengBMCJournal of Translational Medicine1479-58762012-11-0110122610.1186/1479-5876-10-226Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancerMarkiewicz AleksandraAhrends TomaszWełnicka-Jaśkiewicz MarzenaSeroczyńska BarbaraSkokowski JarosławJaśkiewicz JanuszSzade JolantaBiernat WojciechŻaczek Anna J<p>Abstract</p> <p>Background</p> <p>Breast cancers are phenotypically and genotypically heterogeneous tumors containing multiple cancer cell populations with various metastatic potential. Aggressive tumor cell subpopulations might more easily be captured in lymph nodes metastases (LNM) than in primary tumors (PT). We evaluated mRNA and protein levels of master EMT regulators: TWIST1, SNAIL and SLUG, protein levels of EMT-related markers: E-cadherin, vimentin, and expression of classical breast cancer receptors: HER2, ER and PgR in PT and corresponding LNM. The results were correlated with clinicopathological data and patients outcomes.</p> <p>Methods</p> <p>Formalin-fixed paraffin-embedded samples from PT and matched LNM from 42 stage II-III breast cancer patients were examined. Expression of <it>TWIST1</it>, <it>SNAIL</it> and <it>SLUG</it> was measured by reverse-transcription quantitative PCR. Protein expression was examined by immunohistochemistry on tissue microarrays. Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were compared using F-Cox test. Hazard ratios (HRs) with 95% confidence intervals (95% CI) were computed using Cox regression analysis.</p> <p>Results</p> <p>On average, mRNA expression of <it>TWIST1</it>, <it>SNAIL</it> and <it>SLUG</it> was significantly higher in LNM compared to PT (P < 0.00001 for all). Gene and protein levels of TWIST1, SNAIL and SLUG were highly discordant between PT and matched LNM. Increased mRNA expression of <it>TWIST1</it> and <it>SNAIL</it> in LNM was associated with shorter OS (P = 0.04 and P = 0.02, respectively) and DFS (P = 0.02 and P = 0.01, respectively), whereas their expression in PT had no prognostic impact. Negative-to-positive switch of SNAIL protein correlated with decreased OS and DFS (HR = 4.6; 1.1-18.7; P = 0.03 and HR = 3.8; 1.0-48.7; P = 0.05, respectively).</p> <p>Conclusions</p> <p>LNM are enriched in cells with more aggressive phenotype, marked by elevated levels of EMT regulators. High expression of TWIST1 and SNAIL in LNM, as well as negative-to-positive conversion of SNAIL confer worse prognosis, confirming the correlation of EMT with aggressive disease behavior. Thus, molecular profiling of LNM may be used as surrogate marker for aggressiveness and metastatic potential of PT.</p> http://www.translational-medicine.com/content/10/1/226Breast cancerPrimary tumorLymph node metastasisGene expressionImmunohistochemistryBiomarkersEpithelial-mesenchymal transition
collection DOAJ
language English
format Article
sources DOAJ
author Markiewicz Aleksandra
Ahrends Tomasz
Wełnicka-Jaśkiewicz Marzena
Seroczyńska Barbara
Skokowski Jarosław
Jaśkiewicz Janusz
Szade Jolanta
Biernat Wojciech
Żaczek Anna J
spellingShingle Markiewicz Aleksandra
Ahrends Tomasz
Wełnicka-Jaśkiewicz Marzena
Seroczyńska Barbara
Skokowski Jarosław
Jaśkiewicz Janusz
Szade Jolanta
Biernat Wojciech
Żaczek Anna J
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
Journal of Translational Medicine
Breast cancer
Primary tumor
Lymph node metastasis
Gene expression
Immunohistochemistry
Biomarkers
Epithelial-mesenchymal transition
author_facet Markiewicz Aleksandra
Ahrends Tomasz
Wełnicka-Jaśkiewicz Marzena
Seroczyńska Barbara
Skokowski Jarosław
Jaśkiewicz Janusz
Szade Jolanta
Biernat Wojciech
Żaczek Anna J
author_sort Markiewicz Aleksandra
title Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
title_short Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
title_full Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
title_fullStr Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
title_full_unstemmed Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
title_sort expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2012-11-01
description <p>Abstract</p> <p>Background</p> <p>Breast cancers are phenotypically and genotypically heterogeneous tumors containing multiple cancer cell populations with various metastatic potential. Aggressive tumor cell subpopulations might more easily be captured in lymph nodes metastases (LNM) than in primary tumors (PT). We evaluated mRNA and protein levels of master EMT regulators: TWIST1, SNAIL and SLUG, protein levels of EMT-related markers: E-cadherin, vimentin, and expression of classical breast cancer receptors: HER2, ER and PgR in PT and corresponding LNM. The results were correlated with clinicopathological data and patients outcomes.</p> <p>Methods</p> <p>Formalin-fixed paraffin-embedded samples from PT and matched LNM from 42 stage II-III breast cancer patients were examined. Expression of <it>TWIST1</it>, <it>SNAIL</it> and <it>SLUG</it> was measured by reverse-transcription quantitative PCR. Protein expression was examined by immunohistochemistry on tissue microarrays. Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were compared using F-Cox test. Hazard ratios (HRs) with 95% confidence intervals (95% CI) were computed using Cox regression analysis.</p> <p>Results</p> <p>On average, mRNA expression of <it>TWIST1</it>, <it>SNAIL</it> and <it>SLUG</it> was significantly higher in LNM compared to PT (P < 0.00001 for all). Gene and protein levels of TWIST1, SNAIL and SLUG were highly discordant between PT and matched LNM. Increased mRNA expression of <it>TWIST1</it> and <it>SNAIL</it> in LNM was associated with shorter OS (P = 0.04 and P = 0.02, respectively) and DFS (P = 0.02 and P = 0.01, respectively), whereas their expression in PT had no prognostic impact. Negative-to-positive switch of SNAIL protein correlated with decreased OS and DFS (HR = 4.6; 1.1-18.7; P = 0.03 and HR = 3.8; 1.0-48.7; P = 0.05, respectively).</p> <p>Conclusions</p> <p>LNM are enriched in cells with more aggressive phenotype, marked by elevated levels of EMT regulators. High expression of TWIST1 and SNAIL in LNM, as well as negative-to-positive conversion of SNAIL confer worse prognosis, confirming the correlation of EMT with aggressive disease behavior. Thus, molecular profiling of LNM may be used as surrogate marker for aggressiveness and metastatic potential of PT.</p>
topic Breast cancer
Primary tumor
Lymph node metastasis
Gene expression
Immunohistochemistry
Biomarkers
Epithelial-mesenchymal transition
url http://www.translational-medicine.com/content/10/1/226
work_keys_str_mv AT markiewiczaleksandra expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT ahrendstomasz expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT wełnickajaskiewiczmarzena expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT seroczynskabarbara expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT skokowskijarosław expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT jaskiewiczjanusz expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT szadejolanta expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT biernatwojciech expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
AT zaczekannaj expressionofepithelialtomesenchymaltransitionrelatedmarkersinlymphnodemetastasesasasurrogateforprimarytumormetastaticpotentialinbreastcancer
_version_ 1716797316804902912